Contact Information
Email
k****@dbv-technologies.com
Unlock
Company Information
Annual Revenue
12514000.0
Technologies
Outlook
Microsoft Office 365
Remote
AI
Keywords
allergy
food & pediatric allergy
specific immunotherapy
biotechnology: biological products (no diagnostic substances)
health care
biotechnology research
food allergies
peanut allergy
viaskin technology
epicutaneous immunotherapy
clinical trials
immunological diseases
viaskin peanut
cows milk allergy
eoe treatment
immune system re-education
investigational therapies
patch-based treatment
biopharmaceutical company
pediatric clinical trials
non-ige-mediated allergies
pharmaceutical research
safety & efficacy
treatment options
patient care
allergic reactions
anaphylaxis prevention
innovative healthcare
diagnostic tools
atopy patch test
safety data
long-term studies
collaboration with hospitals
allergy research
clinical development programs
phase 3 trials
allergy treatment advancements
children with allergies
gluten-free solutions
autoimmune disease research
scientific publications
consumer health solutions
international healthcare
investor relations
biotechnology innovations
patient-centered approach
regulatory approval
immune therapy
therapeutic advancements
global health initiatives
medical need
clinical effectiveness
healthcare investments
life science partnerships
biopharmaceutical
immunotherapy
non-invasive treatment
cow's milk allergy
pediatric care
allergen desensitization
innovative therapies
patient-centric care
healthcare solutions
allergy management
health-conscious parents
urban healthcare access
treatment pipeline
clinical-stage company
fda fast track designation
allergy patch
therapeutic innovation
quality of life improvement
healthcare collaboration
market research
digital engagement
health advocacy
health
wellness & fitness
hospital & health care
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans